A groundbreaking study challenges decades of medical practice by showing that a less restrictive diet is just as safe for transplant patients as the traditional neutropenic diet.
Learn about the promising combination therapy of elranatamab, carfilzomib and dexamethasone for relapsed or refractory multiple myeloma.
Analysis of the CANOPY-1 trial results examining canakinumab's effectiveness in advanced non-small cell lung cancer treatment.